accountof the first-ever validated microRNA diagnostic assay for pancreatic cancer, quantitative RNA tests for leukemia gene translocations, innovative genetic testing solutions for the fragile X mental retardation (FMR1) gene, Signature(R) Oncology products...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Asuragen Announces Launch of Inform(TM)Thyroid Panel in Its CAP Accredited CLIA Laboratory
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account